VAJRO, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 23.572
AS - Asia 8.207
EU - Europa 5.696
SA - Sud America 511
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 41
OC - Oceania 15
Totale 38.090
Nazione #
US - Stati Uniti d'America 23.431
HK - Hong Kong 3.557
UA - Ucraina 1.684
CN - Cina 1.644
SG - Singapore 1.365
IT - Italia 1.352
DE - Germania 709
RU - Federazione Russa 552
IE - Irlanda 524
BR - Brasile 464
VN - Vietnam 452
IL - Israele 369
FI - Finlandia 356
KR - Corea 339
TR - Turchia 292
SE - Svezia 211
CA - Canada 108
GB - Regno Unito 80
IN - India 63
FR - Francia 56
EU - Europa 47
AT - Austria 43
ES - Italia 28
MX - Messico 27
PL - Polonia 22
BD - Bangladesh 20
NL - Olanda 20
ZA - Sudafrica 19
AR - Argentina 17
IQ - Iraq 16
JP - Giappone 14
PK - Pakistan 14
CZ - Repubblica Ceca 13
VE - Venezuela 12
AU - Australia 11
IR - Iran 11
LT - Lituania 10
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
EG - Egitto 6
UZ - Uzbekistan 6
DK - Danimarca 5
EC - Ecuador 5
RO - Romania 5
BY - Bielorussia 4
GR - Grecia 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
AL - Albania 3
CH - Svizzera 3
CO - Colombia 3
ID - Indonesia 3
JO - Giordania 3
MA - Marocco 3
NP - Nepal 3
OM - Oman 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
PY - Paraguay 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
SR - Suriname 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 38.090
Città #
Ann Arbor 5.988
Hong Kong 3.553
Woodbridge 2.960
Wilmington 2.672
Jacksonville 2.047
Houston 1.679
Chandler 1.531
Princeton 1.425
Dallas 638
Dublin 517
Singapore 491
Ashburn 443
Dong Ket 407
Nanjing 364
Andover 354
Dearborn 349
Boardman 305
Pellezzano 286
Izmir 277
Mestre 277
Beijing 270
Düsseldorf 223
Moscow 156
Salerno 142
Fairfield 129
Shenyang 124
Nanchang 119
Changsha 114
Hebei 114
Jiaxing 101
Los Angeles 86
Tianjin 85
Norwalk 79
Naples 71
Ottawa 61
São Paulo 54
Jinan 49
Brooklyn 45
New York 40
Munich 39
Seattle 39
Washington 37
San Diego 35
Cambridge 29
Guangzhou 29
The Dalles 29
Santa Clara 28
Redwood City 27
Vienna 26
Council Bluffs 25
San Francisco 25
Chicago 24
Columbus 24
Pune 24
Nuremberg 23
Boston 20
Stockholm 20
Atlanta 19
Ho Chi Minh City 18
Johannesburg 18
Venezia 18
Belo Horizonte 17
Charlotte 17
Falls Church 17
Hangzhou 17
London 17
Warsaw 17
Dormagen 16
Napoli 16
Rio de Janeiro 16
Springfield 16
Hefei 15
Kunming 15
Manchester 15
Phoenix 15
Tappahannock 15
Shanghai 14
Brno 13
Rome 13
Tokyo 13
Zhengzhou 13
Fort Worth 12
Milan 12
Montreal 12
Helsinki 11
Mexico City 11
Turku 11
Chennai 9
Costa Mesa 9
Toronto 9
Amorosi 8
Amsterdam 8
Campinas 8
Edinburgh 8
Frankfurt am Main 8
Grevenbroich 8
Prineville 8
Wuhan 8
Esslingen am Neckar 7
Fuzhou 7
Totale 29.682
Nome #
Clinical features and genotype-phenotype correlations in children withprogressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. 553
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 488
Efficacy of a multi-compartmental obesity prevention program (the 3P Project) in South Italy preschoolers 371
Migrazione sanitaria pediatrica: analisi epidemiologica, statistica, sociale ed economica del fenomeno in Campania 364
Characterization and burden of Campania children health migration across Italian regions during years 2006–2010: chance and/or necessity? 302
Autoimmune liver disease associated with celiac disease in childhood: a multicenter study 254
Celiac Disease-Associated Autoimmune Hepatitis In Childhood: Long Term Response To Treatment 228
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 206
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 206
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 205
Brain abscess due to Klebsiella Pneumoniae in liver-transplanted children 185
Ipertransaminasemia cronica idiopatica 180
Fas apo1 mutations and defective Fas-mediated apoptosis in a child with type 2a autoimmune hepatitis 176
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. 174
Evaluation of hyaluronic acid (HA) and laminin (LAM) serum levels as quantitative markers of histomorphometry-proven liver fibrosis in children with chronic B hepatitis. 173
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review 167
Low rate sustained response to IFN therapy in children with chronic hepatitis C (CHC) 160
Humanization interventions in general pediatric wards: a systematic review 157
Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in theLiver of Young Rats 156
Deficit staturo-ponderale nel bambino: non sempre un problema esclusivamente endocrinologico. 156
Diagnosis of hepatopulmonary sindrome (HPS) in children with chronic liver disease (CLD) 154
MITOCHONDRIAL DYSFUNCTION AND AUTOIMMUNITY PHENOMENA IN SHWACHMAN-DIAMOND SYNDROME RELATED LIVER DISEASE. 153
Genotype-phenotype correlation in Italian children with Wilson Disease 146
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 144
Recombinant interferon-alfa therapy in children with chronic hepatitis C 143
Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. 143
Prevalence and long term follow up of macroaspartate aminotransferase (macroAST) in children. 141
"Classic" and "new" prothrombotic risk factors in children with portal vein thrombosis. 140
Self-concept and psychopatological risk in liver transplantated children. 140
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. 140
LONG-TERM ZINC THERAPY IN WILSON DISEASE CHILDREN WITH MILD LIVER DISEASE 139
Jagged-1 mutation analysis in Italian Alagille syndrome patients. 138
A 360-Degree Overview Of Paediatric Nafld: Recent Insights 136
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 134
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. 133
A systematic review of pediatrics NAFLD therapy: year 2012 133
IFN in pedaitric chronic hepatitis B (CHB). 132
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 132
An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999 131
Autoimmune liver disorders and celiac dsease in children: the SIGEP CALD study 130
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 130
Atypical celiac disease presenting as obesity-related liver dysfunction. 129
The canine copper toxicosis gene MURR1 is not implicated in thepathogenesis of Wilson disease. 129
Autoimmune liver disorders and coeliac disease in children: the SIGEP CALD study 129
Ophthalmological findings of phenylketonuria: a survey of 14 cases. 128
Health-related quality of life in pediatric liver transplanted patients compared with a chronic liver disease group. 127
Congenital hepatic shunts: a pediatric series. 126
ASYMPTOMATIC HYPERTRANSAMINASEMIA: A STILL POORLY RECOGNIZED MARKER OF EARLY DUCHENNE/BECKER MUSCULAR DYSTROPHY 126
Noninvasive investigation of hepatopulmonary syndrome in children and adolescents with chronic cholestasis. 125
Systematic review and meta-analysis of the association celia disease-liver disease in the pediatric age 125
Approach to the asymptomatic child with protracted hypertransaminasemia 122
Brain abscess due to Klebsiella pneumoniae in a liver-transplanted child 122
Early detection of post-transplant lymphoproliferative disorders (PTLD) and modulation of immune suppression (IS) in liver transplant recipients by means of EBNA 1 and BZLF1 expression monitoring 122
Long-term response to IFN therapy in children with chronic hepatitis C. 121
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 121
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions 121
POST-TRANSPLANT ERYTHROCYTOSIS IN PEDIATRIC LIVER RECIPIENTS: GENETIC ABNORMALITIES OF OXIGEN SENSING PATHWAY, ERYTHROPOIETIN AND JAK2 ARE NOT INVOLVED IN ITS PATHOGENESIS 120
Mutations of ABCB4 gene in children with progressive familial intrahepatic cholestasis: a multicenter Italian study. 120
Diagnosis of nonalcoholic fatty liver disease inchildren and adolescents: position paper of the ESPGHAN Hepatology Committee 120
Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency. 120
A practical approach to the child with abnormal liver tests. 120
YEAR 2010: SYSTEMATIC REVIEW OF TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN CHILDREN AND ADOLESCENTS 119
COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. 118
Breast feeding enhances the clearance of HBsAg in infants with hepatitis B virus infection. 118
A comparison of toddlers milk: are all the same? 118
Pediatric Celiac Disease, Cryptogenic Hypertransaminasemia, and Autoimmune Hepatitis. 118
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 117
‘3P (Preschool Prevention Program)’: Preliminary Results Of A Pilot Project For Early Obesity Prevention And Mediterranean Diet Promotion 116
Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Non-alcoholic Steatohepatitis: the ESPGHAN Hepatology Committee Position Statement 116
Incidence of cirrhosis in children with chronic hepatitis. 116
Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. 116
Multiple phenotypes in phosphoglucomutase 1 deficiency. 116
Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. 116
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 115
Posttransfusion and community-acquired hepatitis C in childhood. 114
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period 114
Pediatric non-alcoholic fatty liver disease: Recent advances. 114
Maternal microbiota, prepregnancy weight, and mode of delivery: Intergenerational transmission of risk for childhood overweight and obesity 114
Hypertransaminasemia and coeliac disease 113
Post-transplant erythrocytosis may affect also liver recipients. 113
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 113
A case of galactosemia misdiagnosed as cow's milk intolerance 113
Side effects of alpha interferon therapy in 88 children with viral chronic hepatitis. 112
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 111
Volume and emptying of the gallbladder in patients with cystic fibrosis 111
HCV genotypes and hepatitis C in children. 111
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 111
Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease 111
LIVER CHANGES IN EPILEPTIC CHILDREN ARE MAINLY ASSOCIATED WITH FIRST-GENERATION ANTICONVULSANTS 110
Does Small intestine-liver axis play a role in pediatric obesity related liver damage? A pilot study. 110
Alagille syndrome: An overview. 109
Aagenaes's syndrome in an Italian child. 109
EBNA1 and BZLF1 plus IgG serum levels individuate early stages of Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease (PTLD) and helps modulation of immmunosuppression (IS) in liver transplant recipients. 109
Diagnostic significance of postprandial (PP) serum bile acids (BA) in HBsAg+ asymptomatic chronic hepatitis 109
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 109
EARLY STAGE OF DUCHENNE/BECKER MUSCULAR DYSTROPHY-ASSOCIATED HYPERTRANSAMINASEMIA: ANOTHER POSSIBLE COMPONENT OF THE “NASH TRASH BIN”? 108
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 108
Lymph node fine needle cytology in the diagnosis of infectious diseases and instrumental guides: ultrasound and computed tomography 108
Networking Between γc and GH-R Signaling in the Control of Cell Growth 108
Long-term outcome of italian children with biliary atresia after Kasai portoenterostomy 107
Totale 14.644
Categoria #
all - tutte 113.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.439 0 0 360 8 355 76 354 41 376 17 385 467
2021/20222.431 17 3 6 27 64 31 22 104 394 334 319 1.110
2022/20233.881 430 136 82 409 621 859 5 366 698 20 171 84
2023/20241.553 143 306 99 76 96 163 66 84 19 80 81 340
2024/20253.441 184 86 112 140 118 547 472 403 423 191 370 395
2025/20264.847 1.031 3.749 67 0 0 0 0 0 0 0 0 0
Totale 38.696